42 Results

People

  1. Lilja
    Lilja
  2. Vickers
    Vickers
  3. Cronin
    Cronin
  4. Scardino
    Scardino
  5. Savage
    Savage
  6. Carlsson
    Carlsson
  7. Ulmert
    Ulmert
  8. Eastham
    Eastham
  9. Sjoberg
    Sjoberg
  10. Assel
    Assel

Groups

  1. Epidemiology and Biostatistics (42)
  2. Health Outcomes Research Group (42)
  3. Population Sciences Research Program (42)
  4. Surgery (42)
  5. Urology (42)
  6. Molecular Pharmacology and Chemistry Program Faculty (20)
  7. Sloan Kettering Institute Faculty (20)
  8. Sloan Kettering Institute Postdocs (8)
  9. Clinical Genetics Service (2)
  10. Department of Medicine (2)
  1. "adult"
  2. "Health Outcomes Research Group"
  3. "Hans Lilja"
Formats
  1. Journal Article (42)
Groups
  1. Epidemiology and Biostatistics (42)
  2. Health Outcomes Research Group (42)
  3. Population Sciences Research Program (42)
  4. Surgery (42)
  5. Urology (42)
  6. Molecular Pharmacology and Chemistry Program Faculty (20)

More Groups

People
  1. Hans Lilja (42)
  2. Andrew Vickers (39)
  3. Peter Scardino (20)
  4. Angel Cronin (18)
  5. Caroline Savage (10)
  6. Daniel Sjoberg (8)

More People

Years
  1. 2023 (1)
  2. 2020 (2)
  3. 2019 (3)
  4. 2018 (4)
  5. 2015 (3)
  6. 2014 (1)

More Years

Publications
  1. European Urology (10)
  2. Clinical Cancer Research (4)
  3. BJU International (3)
  4. British Journal of Cancer (3)
  5. International Journal of Cancer (3)
  6. JNCI: Journal of the National Cancer Institute (3)

More Publications

Publishers
  1. Elsevier Science, Inc. (12)
  2. American Association for Cancer Research (6)
  3. Wiley Blackwell (5)
  4. John Wiley & Sons (4)
  5. Nature Publishing Group (4)
  6. American Society of Clinical Oncology (3)

More Publishers

Results (42)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Young age on starting prostate-specific antigen testing is associated with a greater reduction in prostate cancer mortality: 24-year follow-up of the Göteborg randomized population-based prostate cancer screening trial
    Journal Article

    Carlsson, S. V.; Arnsrud Godtman, R.; Pihl, C. G.; Vickers, A.; Lilja, H.; Hugosson, J.; Månsson, M.
    European Urology (2023)

    Fulltext@MSK | Save
  • A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy
    Journal Article

    Haese, A.; Tin, A. L.; Carlsson, S. V.; Sjoberg, D. D.; Pehrke, D.; Steuber, T.; Huland, H.; Graefen, M.; Scardino, P. T.; Schlomm, T.; more...
    British Journal of Cancer (2020)

    Fulltext@MSK | Save
  • Kallikrein markers performance in pretreatment blood to predict early prostate cancer recurrence and metastasis after radical prostatectomy among very high-risk men
    Journal Article

    Assel, M. J.; Ulmert, H. D.; Karnes, R. J.; Boorjian, S. A.; Hillman, D. W.; Vickers, A. J.; Klee, G. G.; Lilja, H.
    Prostate (2020)

    Fulltext@MSK | Save
  • Interim results from the IMPACT study: Evidence for prostate-specific antigen screening in BRCA2 mutation carriers
    Journal Article

    Page, E. C.; Bancroft, E. K.; Brook, M. N.; Assel, M.; Al Battat, M. H.; Thomas, S.; Taylor, N.; Chamberlain, A.; Pope, J.; Raghallaigh, H. N.; more...
    European Urology (2019)

    Fulltext@MSK | Save
  • A 16-yr follow-up of the European Randomized study of Screening for Prostate Cancer
    Journal Article

    Hugosson, J.; Roobol, M. J.; Månsson, M.; Tammela, T. L. J.; Zappa, M.; Nelen, V.; Kwiatkowski, M.; Lujan, M.; Carlsson, S. V.; Talala, K. M.; more...
    European Urology (2019)

    Fulltext@MSK | Save
  • Baseline prostate-specific antigen level in midlife and aggressive prostate cancer in black men
    Journal Article

    Preston, M. A.; Gerke, T.; Carlsson, S. V.; Signorello, L.; Sjoberg, D. D.; Markt, S. C.; Kibel, A. S.; Trinh, Q. D.; Steinwandel, M.; Blot, W.; more...
    European Urology (2019)

    Fulltext@MSK | Save
  • Twenty-year risk of prostate cancer death by midlife prostate-specific antigen and a panel of four kallikrein markers in a large population-based cohort of healthy men
    Journal Article

    Sjoberg, D. D.; Vickers, A. J.; Assel, M.; Dahlin, A.; Poon, B. Y.; Ulmert, D.; Lilja, H.
    European Urology (2018)

    Fulltext@MSK | Save
  • Association between lead time and prostate cancer grade: Evidence of grade progression from long-term follow-up of large population-based cohorts not subject to prostate-specific antigen screening
    Journal Article

    Assel, M.; Dahlin, A.; Ulmert, D.; Bergh, A.; Stattin, P.; Lilja, H.; Vickers, A. J.
    European Urology (2018)

    Fulltext@MSK | Save
  • Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition
    Journal Article

    Mikropoulos, C.; Hutten Selkirk, C. G.; Saya, S.; Bancroft, E.; Vertosick, E.; Dadaev, T.; Brendler, C.; Page, E.; Dias, A.; Evans, D. G.; more...
    British Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Long-term prediction of prostate cancer diagnosis and death using PSA and obesity related anthropometrics at early middle age: Data from the Malmö Preventive Project
    Journal Article

    Assel, M. J.; Gerdtsson, A.; Thorek, D. L. J.; Carlsson, S. V.; Malm, J.; Scardino, P. T.; Vickers, A.; Lilja, H.; Ulmert, D.
    Oncotarget (2018)

    Fulltext@MSK | Save